Impact of enzyme concentration and residence time on apparent activity recovery in jump dilution analysis.

作者: Robert A. Copeland , Aravind Basavapathruni , Mikel Moyer , Margaret Porter Scott

DOI: 10.1016/J.AB.2011.05.029

关键词:

摘要: Jump dilution analysis is commonly used to evaluate the reversibility of inhibition and quantify residence time inhibitor-enzyme complex. During hit lead characterization, one sometimes observes apparently linear progress curves after jump that display activity recoveries are intermediate between those expected for fully reversible irreversible inhibition. Computer simulations indicate seemingly can result when dealing with tight-binding inhibitors if substoichiometric concentrations inhibitor preincubated enzyme. In this situation, recovered comparable instantaneously inhibitors. addition, demonstrate values recovery may be observed compounds modestly slow dissociation rates (i.e., times >0min but ≤20min) attending curvature data not accounted for. The observation can, thus, serve as an indication either modest or a contaminating inactivator within sample, in case prompting greater scrutiny test compound.

参考文章(15)
John F. Morrison, Christopher T. Walsh, The Behavior and Significance of Slow-Binding Enzyme Inhibitors Advances in Enzymology - and Related Areas of Molecular Biology. ,vol. 61, pp. 201- 301 ,(1988) , 10.1002/9780470123072.CH5
L C Mahan, H J Motulsky, The kinetics of competitive radioligand binding predicted by the law of mass action. Molecular Pharmacology. ,vol. 25, pp. 1- 9 ,(1984)
Robert A. Copeland, David L. Pompliano, Thomas D. Meek, Drug–target residence time and its implications for lead optimization Nature Reviews Drug Discovery. ,vol. 5, pp. 730- 739 ,(2006) , 10.1038/NRD2082
Peter J. Tummino, Robert A. Copeland, Residence time of receptor-ligand complexes and its effect on biological function. Biochemistry. ,vol. 47, pp. 5481- 5492 ,(2008) , 10.1021/BI8002023
Kerim Babaoglu, Anton Simeonov, John J Irwin, Michael E Nelson, Brian Feng, Craig J Thomas, Laura Cancian, M Paola Costi, David A Maltby, Ajit Jadhav, James Inglese, Christopher P Austin, Brian K Shoichet, None, Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase Journal of Medicinal Chemistry. ,vol. 51, pp. 2502- 2511 ,(2008) , 10.1021/JM701500E
Matthew A. Cooper, Optical biosensors in drug discovery. Nature Reviews Drug Discovery. ,vol. 1, pp. 515- 528 ,(2002) , 10.1038/NRD838
Johan Gabrielsson, Hugues Dolgos, Per-Göran Gillberg, Ulf Bredberg, Bert Benthem, Göran Duker, Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations. Drug Discovery Today. ,vol. 14, pp. 358- 372 ,(2009) , 10.1016/J.DRUDIS.2008.12.011
G VAUQUELIN, I VANLIEFDE, Slow antagonist dissociation and long-lasting in vivo receptor protection Trends in Pharmacological Sciences. ,vol. 27, pp. 355- 359 ,(2006) , 10.1016/J.TIPS.2006.05.001
Kang Yan, Lenore Madden, Anthony E. Choudhry, Christine S. Voigt, Robert A. Copeland, Richard R. Gontarek, Biochemical Characterization of the Interactions of the Novel Pleuromutilin Derivative Retapamulin with Bacterial Ribosomes Antimicrobial Agents and Chemotherapy. ,vol. 50, pp. 3875- 3881 ,(2006) , 10.1128/AAC.00184-06